ClinicalTrialsFinder

RecruitingNCT06433752

A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)

REal World ExperieNce With BRIUMVI® (UblituximAB-xiiy) Treated Patients: A Longitudinal REgistry Study (ENABLE)

Sponsor

TG Therapeutics, Inc.

Enrollment

500 participants

Start Date

Jul 22, 2024

Study Type

OBSERVATIONAL

Conditions

Multiple Sclerosis Relapsing Multiple Sclerosis

Summary

The purpose of this study is to evaluate safety, effiectiveness, and to gain insight into the treatment experience of participants prescribed BRIUMVI® (ublituximab-xiiy) in the real-world setting

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting real-world information about how people with relapsing multiple sclerosis (MS) respond to BRIUMVI (ublituximab-xiiy), a newer infusion treatment for MS, in everyday clinical practice outside of a controlled trial setting. **You may be eligible if...** - You have a confirmed diagnosis of multiple sclerosis (MS) - You have been prescribed BRIUMVI but have not yet received your first infusion, or you are about to begin treatment - You have not previously received BRIUMVI infusions before joining the study **You may NOT be eligible if...** - You received a live vaccine (such as chickenpox or measles) within 4 weeks before your first infusion, or a non-live vaccine within 2 weeks - You have an active infection (such as active Hepatitis B) - You are currently enrolled in another MS treatment trial or are receiving another MS-modifying therapy at the same time Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo Intervention

No Intervention

Locations(85)

TG Therapeutics Investigational Trial Site

Birmingham, Alabama, United States

TG Therapeutics Investigational Trial Site

Huntsville, Alabama, United States

TG Therapeutics Investigational Trial Site

Mobile, Alabama, United States

TG Therapeutics Investigational Trial Site

Gilbert, Arizona, United States

TG Therapeutics Investigational Trial Site

Phoenix, Arizona, United States

TG Therapeutics Investigational Trial Site

Scottsdale, Arizona, United States

TG Therapeutics Investigational Trial Site

Fresno, California, United States

TG Therapeutics Investigational Trial Site

Newport Beach, California, United States

TG Therapeutics Investigational Trial Site

Orange, California, United States

TG Therapeutics Investigational Trial Site

West Hollywood, California, United States

TG Therapeutics Investigational Trial Site

Aurora, Colorado, United States

TG Therapeutics Investigational Trial Site

Basalt, Colorado, United States

TG Therapeutics Investigational Trial Site

Colorado Springs, Colorado, United States

TG Therapeutics Investigational Trial Site

Denver, Colorado, United States

TG Therapeutics Investigational Trial Site

Fort Collins, Colorado, United States

TG Therapeutics Investigational Trial Site

Grand Junction, Colorado, United States

TG Therapeutics Investigational Trial Site

Farmington, Connecticut, United States

TG Therapeutics Investigational Trial Site

Hartford, Connecticut, United States

TG Therapeutics Investigational Trial Site

Wilmington, Delaware, United States

TG Therapeutics Investigational Trial Site

Washington D.C., District of Columbia, United States

TG Therapeutics Investigational Trial Site

Altamonte Springs, Florida, United States

TG Therapeutics Investigational Trial Site

Boca Raton, Florida, United States

TG Therapeutics Investigational Trial Site

Clearwater, Florida, United States

TG Therapeutics Investigational Trial Site

Maitland, Florida, United States

TG Therapeutics Investigational Trial Site

Miami, Florida, United States

TG Therapeutics Investigational Trial Site

Naples, Florida, United States

TG Therapeutics Investigational Trial Site

Weston, Florida, United States

TG Therapeutics Investigational Trial Site

Atlanta, Georgia, United States

TG Therapeutics Investigational Trial Site

Atlanta, Georgia, United States

TG Therapeutics Investigational Trial Site

Smyrna, Georgia, United States

TG Therapeutics Investigational Trial Site

Coeur d'Alene, Idaho, United States

TG Therapeutics Investigational Trial Site

Chicago, Illinois, United States

TG Therapeutics Investigational Trial Site

Evanston, Illinois, United States

TG Therapeutics Investigational Trial Site

Urbana, Illinois, United States

TG Therapeutics Investigational Trial Site

Lexington, Kentucky, United States

TG Therapeutics Investigational Trial Site

Louisville, Kentucky, United States

TG Therapeutics Investigational Trial Site

Baltimore, Maryland, United States

TG Therapeutics Investigational Trial Site

Glen Burnie, Maryland, United States

TG Therapeutics Investigational Trial Site

Boston, Massachusetts, United States

TG Therapeutics Investigational Trial Site

Burlington, Massachusetts, United States

TG Therapeutics Investigational Trial Site

Norfolk, Massachusetts, United States

TG Therapeutics Investigational Trial Site

Ann Arbor, Michigan, United States

TG Therapeutics Investigational Trial Site

Farmington, Michigan, United States

TG Therapeutics Investigational Trial Site

Owosso, Michigan, United States

TG Therapeutics Investigational Trial Site

Rochester Hills, Michigan, United States

TG Therapeutics Investigational Trial Site

Omaha, Nebraska, United States

TG Therapeutics Investigational Trial Site

Las Vegas, Nevada, United States

TG Therapeutics Investigational Trial Site

Bridgewater, New Jersey, United States

TG Therapeutics Investigational Trial Site

Cherry Hill, New Jersey, United States

TG Therapeutics Investigational Trial Site

Freehold, New Jersey, United States

TG Therapeutics Investigational Trial Site

Livingston, New Jersey, United States

TG Therapeutics Investigational Trial Site

Neptune City, New Jersey, United States

TG Therapeutics Investigational Trial Site

Teaneck, New Jersey, United States

TG Therapeutics Investigational Trial Site

Amherst, New York, United States

TG Therapeutics Investigational Trial Site

New York, New York, United States

TG Therapeutics Investigational Trial Site

Charlotte, North Carolina, United States

TG Therapeutics Investigational Trial Site

New Bern, North Carolina, United States

TG Therapeutics Investigational Trial Site

Raleigh, North Carolina, United States

TG Therapeutics Investigational Trial Site

Centerville, Ohio, United States

TG Therapeutics Investigational Trial Site

Centerville, Ohio, United States

TG Therapeutics Investigational Trial Site

Cincinnati, Ohio, United States

TG Therapeutics Investigational Trial Site

Cleveland, Ohio, United States

TG Therapeutics Investigational Trial Site

Columbus, Ohio, United States

TG Therapeutics Investigational Trial Site

Toledo, Ohio, United States

TG Therapeutics Investigational Trial Site

Portland, Oregon, United States

TG Therapeutics Investigational Trial Site

Bethlehem, Pennsylvania, United States

TG Therapeutics Investigational Trial Site

Knoxville, Tennessee, United States

TG Therapeutics Investigational Trial Site

Nashville, Tennessee, United States

TG Therapeutics Investigational Trial Site

Spring Hill, Tennessee, United States

TG Therapeutics Investigational Trial Site

Austin, Texas, United States

TG Therapeutics Investigational Trial Site

Austin, Texas, United States

TG Therapeutics Investigational Trial Site

Austin, Texas, United States

TG Therapeutics Investigational Trial Site

Dallas, Texas, United States

TG Therapeutics Investigational Trial Site

Edinburg, Texas, United States

TG Therapeutics Investigational Trial Site

San Antonio, Texas, United States

TG Therapeutics Investigational Trial Site

Charlottesville, Virginia, United States

TG Therapeutics Investigational Trial Site

Norfolk, Virginia, United States

TG Therapeutics Investigational Trial Site

Vienna, Virginia, United States

TG Therapeutics Investigational Trial Site

Kirkland, Washington, United States

TG Therapeutics Investigational Trial Site

Morgantown, West Virginia, United States

TG Therapeutics Investigational Trial Site

Greenfield, Wisconsin, United States

TG Therapeutics Investigational Trial Site

Milwaukee, Wisconsin, United States

TG Therapeutics Investigational Trial Site

Neenah, Wisconsin, United States

TG Therapeutics Investigational Trial Site

Waukesha, Wisconsin, United States

TG Therapeutics Investigational Trial Site

Guaynabo, Puerto Rico

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT06433752

Related Trials

Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?

NCT053577811 location

Magnetic Resonance Imaging (MRI) to Evaluate Activity of Multiple Sclerosis (MS)

NCT000012481 location

Effect of Corticosteroids on Inflammation at the Edge of Acute Multiple Sclerosis Plaques

NCT027842101 location

Central Nervous System Uptake of Anti-CD8+ T Cell Minibodies in Multiple Sclerosis and Progressive Multifocal Leukoencephalopathy

NCT058494671 location

Blood Flow Restriction for Upper Limb Rehabilitation in People With Multiple Sclerosis. A Randomized Controlled Trial (BFRT-EM)

NCT067952301 location